학술논문
CA209-9DX: phase III, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15698041